MedTrace Logo

EVOLVING AZIMUTH IN MUSA CONTEXT

NCT07022067 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2025-06-15

No results posted yet for this study

Summary

Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure

Conditions

Interventions

DEVICE

Telemonitoring app

periodic measurement of blood pressure and body weight

Sponsors & Collaborators

  • ASST Grande Ospedale Metropolitano Niguarda

    collaborator OTHER

  • University of Milan

    collaborator OTHER

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    lead OTHER

Principal Investigators

  • Stefano Prof. Carugo · IRCCS Fondazione Caì Granda Ospedale Maggiore Policlinico

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-02
Primary Completion
2025-06-30
Completion
2025-08-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07022067 on ClinicalTrials.gov